MedPath

Electrical Stimulation to Promote Recovery in Bells Palsy

Not Applicable
Terminated
Conditions
Bell Palsy
Interventions
Device: Electrical stimulation device (tens unit)
Registration Number
NCT03836989
Lead Sponsor
Oregon Health and Science University
Brief Summary

A feasibility pilot study to exam the necessary methodology for conducting a larger clinical trial for Bell's Palsy patients with a poor prognosis and the use of electrical stimulation.

Detailed Description

Here we describe a protocol for a prospective, randomized, double-blinded study to evaluate the effects of monophasic pulsed current ES on patients with Bell's palsy and factors predicting poor recovery, with a 6 month follow up. Motor level stimulation with a pulse duration of 100 μsec and a frequency of 35 pulses per second were chosen from focus group with physical therapist to treat facial paralysis and are consistent with clinical trials showing motor benefit after capel tunnel surgery.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • New diagnosis of bell's palsy (diagnosed in the last 30 days)
  • IF younger than 60 years of age must have complete paralysis on one side of face or both
  • IF older than 60 years of age paralysis must be present but CAN be incomplete.
Exclusion Criteria
  • Paralysis associated with any of the fallowing: cancer, tumor, surgery, stroke, or trauma.
  • Younger than 60 years old with INCOMPLETE paralysis.
  • Non English speakers
  • Pacemaker or deep brain stimulator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-volt electrical stimulationElectrical stimulation device (tens unit)Plan to use a monophasic waveform having 100µmsec pulse duration, at 35 Hz using tolerated voltage to generate a contraction a total of 20 minutes. The stimulation will have 10 seconds on time, 30 seconds off time and 2 second ramp up and down. Electrical stimulation will be produced with the Orthostim 3 device (VQ Ortho Care). The cathode will be placed on the ipsilateral muscle to stimulate and the anode over the ipsilateral mastoid region. Four facial muscles will be stimulated: 1)frontalis, 2) orbicularis oculi, 3) zygomaticus major, and 4) orbicularis oris. The voltage is turned up by the participant until he or she can see twitches or as high as tolerated. Ten contractions in each muscle group will be performed or 5 minutes per muscle if no contraction is achieved.
Subsensory electrical stimulationElectrical stimulation device (tens unit)Plan to use the same device and settings to provide placebo treatment by delivering minimal electricity. The settings will be the same as the intervention except the voltage will be subsensory. ie. below the minimum at which patients feels any effect of the current. The voltage is turned down two clicks from the voltage at which the participant can first notice any electricity or at the minimal setting.
Primary Outcome Measures
NameTimeMethod
Recovery at 3 Months as Measured From Facial Photos With Different Facial Expressions3 months

To evaluate for complete recovery, standardized photos of patients at rest, and during movement, will be evaluated by three treatment-blinded otolaryngologists. Total number of patients fully recovered over number of participants will be reported.

Secondary Outcome Measures
NameTimeMethod
Eye ClosureBaseline and 3 months

Measuring in millimeters of the eyelids remaining open during maximal eye closure using the MEEI FACE-gram program

Smile ExcursionBaseline and 3 months

Measuring oral commissure exclusion using the MEEI FACE-gram program reported as the change in millimeters in the distance between the midline of the lower lip and the oral commissure in comparison between rest and smile

Self Reported Subject Adherence3 months

Percentage of subjected who reported full adherence, partial adherence and non-adherence confirmed by comparing to the daily diary of use.

Patient Reported Global Quality of Life Specific to Facial ParalysisBaseline, 3 months and 6 months

Measured by the validated quality of life patient reported questionnaire Facial Clinimetric Evaluation (FaCE) Scale with a scale from 0 (normal) to 100 (severe dysfunction). The scale encompasses facial movement, facial comfort, oral function, eye comfort, lacrimal control, and social function.

House Brackmann ScaleBaseline, and 3 months

Determined by three blinded otolaryngologist reviewing facial photos of patients with smile and eye closure. Reported as an average of the three scores. The scales ranges from 1 (normal) to 6 (most severe dysfunction)

Patient Reported Quality of Life in Relation to Facial Synkinesis Measured by the Synkinesis Assessment Questionnaire (SAQ)Baseline, 3 months and 6 months

Quality of life is in part measured in this study using the patient reported Synkinesis Assessment Questionnaire (SAQ). The instrument consisting of 10 items asks participants how difficult certain facial activities are. Based on the average score for each domain the test gives a score between 20 (no synkinesis) to 100 (severe synkinesis, all the time).

Objective Measurements of Brow ElevationBaseline and in 3 months

Measuring brow elevation using the MEEI FACE-gram program reported as the millimeters in decreased elevation in comparison to the unaffected side

Facial Symmetry During SmileBaseline and 3 months

Measured by facial asymmetry index (FAI) during smile in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals perfect symmetry and no difference in sides. The closer a number is to 0, the greater the symmetry. Ranges have not been published for this scale. FAI does not have a maximum score.

Facial Symmetry at RestBaseline and 3 months

Measured by facial asymmetry index (FAI) at rest in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals no difference between sides and perfect symmetry. The closer a number is to 0, the higher the symmetry is. Ranges have not been published for this scale. FAI does not have a maximum score.

Patient Tolerability3 months

Measured by a visual analog scale (VAS) which ranged from 0 to 10 where 0 stands for completely comfortable and 10 to very uncomfortable. A questionnaire designed by research team using a Likert's scale was created to measure patient tolerability.

Trial Locations

Locations (1)

Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath